These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 15548573)

  • 21. 3. Adhesion molecules and receptors.
    Smith CW
    J Allergy Clin Immunol; 2008 Feb; 121(2 Suppl):S375-9; quiz S414. PubMed ID: 18241685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrins as therapeutic targets.
    Goodman SL; Picard M
    Trends Pharmacol Sci; 2012 Jul; 33(7):405-12. PubMed ID: 22633092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic targeting of alpha 4-integrins in chronic inflammatory diseases: tipping the scales of risk towards benefit?
    Engelhardt B; Briskin MJ
    Eur J Immunol; 2005 Aug; 35(8):2268-73. PubMed ID: 16052610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Review. Leukocyte and endothelial cell adhesion molecules in inflammation focusing on inflammatory heart disease.
    Golias C; Tsoutsi E; Matziridis A; Makridis P; Batistatou A; Charalabopoulos K
    In Vivo; 2007; 21(5):757-69. PubMed ID: 18019409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting adhesion molecules as a potential mechanism of action for intravenous immunoglobulin.
    Gill V; Doig C; Knight D; Love E; Kubes P
    Circulation; 2005 Sep; 112(13):2031-9. PubMed ID: 16172269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic strategies in autoimmune diseases by interfering with leukocyte endothelium interaction.
    Rychly J; Nebe B
    Curr Pharm Des; 2006; 12(29):3799-806. PubMed ID: 17073678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional insights on the polarized redistribution of leukocyte integrins and their ligands during leukocyte migration and immune interactions.
    Barreiro O; de la Fuente H; Mittelbrunn M; Sánchez-Madrid F
    Immunol Rev; 2007 Aug; 218():147-64. PubMed ID: 17624951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measurement of leukocyte rheology in vascular disease: clinical rationale and methodology. International Society of Clinical Hemorheology.
    Wautier JL; Schmid-Schönbein GW; Nash GB
    Clin Hemorheol Microcirc; 1999; 21(1):7-24. PubMed ID: 10517484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic targeting of chemokine signaling in Multiple Sclerosis.
    Hamann I; Zipp F; Infante-Duarte C
    J Neurol Sci; 2008 Nov; 274(1-2):31-8. PubMed ID: 18706659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A small molecule, orally active, alpha4beta1/alpha4beta7 dual antagonist reduces leukocyte infiltration and airway hyper-responsiveness in an experimental model of allergic asthma in Brown Norway rats.
    Cortijo J; Sanz MJ; Iranzo A; Montesinos JL; Nabah YN; Alfón J; Gómez LA; Merlos M; Morcillo EJ
    Br J Pharmacol; 2006 Mar; 147(6):661-70. PubMed ID: 16432509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natalizumab: targeting alpha4-integrins in multiple sclerosis.
    Engelhardt B; Kappos L
    Neurodegener Dis; 2008; 5(1):16-22. PubMed ID: 18075270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Considerations for the sensible use of rodent models of inflammatory disease in predicting efficacy of new biological therapeutics in the clinic.
    Arnett HA; Viney JL
    Adv Drug Deliv Rev; 2007 Sep; 59(11):1084-92. PubMed ID: 17804112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting leukocyte trafficking to inflamed skin: still an attractive therapeutic approach?
    Zollner TM; Asadullah K; Schön MP
    Exp Dermatol; 2007 Jan; 16(1):1-12. PubMed ID: 17181631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrin regulation of lymphocyte trafficking: lessons from structural and signaling studies.
    Kinashi T
    Adv Immunol; 2007; 93():185-227. PubMed ID: 17383542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting integrin structure and function in disease.
    Staunton DE; Lupher ML; Liddington R; Gallatin WM
    Adv Immunol; 2006; 91():111-57. PubMed ID: 16938539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leukocyte extravasation as a target for anti-inflammatory therapy - Which molecule to choose?
    Boehncke WH; Schön MP; Girolomoni G; Griffiths C; Bos JD; Thestrup-Pedersen K; Cavani A; Nestle F; Bonish BK; Campbell JJ; Brakebusch C; Nickoloff B
    Exp Dermatol; 2005 Jan; 14(1):70-80. PubMed ID: 15660923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The alpha4beta1 and alpha5beta1 integrins mediate engraftment of granulocyte-colony-stimulating factor-mobilized human hematopoietic progenitor cells.
    Carstanjen D; Gross A; Kosova N; Fichtner I; Salama A
    Transfusion; 2005 Jul; 45(7):1192-200. PubMed ID: 15987366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The role of integrins in the physiologic and pathogenic processes].
    Borowska K; Jedrych B; Czerny K; Zabielski S
    Pol Merkur Lekarski; 2006 Oct; 21(124):362-6. PubMed ID: 17205779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leukocyte traffic control: a novel therapeutic strategy for inflammatory bowel disease.
    Fiorino G; Correale C; Fries W; Repici A; Malesci A; Danese S
    Expert Rev Clin Immunol; 2010 Jul; 6(4):567-72. PubMed ID: 20594130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrin-based therapeutics: biological basis, clinical use and new drugs.
    Ley K; Rivera-Nieves J; Sandborn WJ; Shattil S
    Nat Rev Drug Discov; 2016 Mar; 15(3):173-83. PubMed ID: 26822833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.